Skip to main content

Table 5 Relationship between antibiotic use and intensive care unit mortality in univariate analysis

From: Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome

 

Survivors (n = 60)

Non-survivors (n = 54)

p value

Antibiotic treatment

38 (63)

47 (87)

<0.003a

Duration of antibiotic treatment, days

7 ± 8

10 ± 10

0.197

Glycopeptide use

9 (15)

11 (20)

0.225

   Duration, days

2 ± 3

1 ± 3

0.399

Extended-spectrum penicillin use

34 (56)

38 (70)

0.099

   Duration, days

8 ± 8

7 ± 8

0.710

Fluoroquinolone use

22 (36)

24 (44)

0.336

   Duration, days

6 ± 6

5 ± 4

0.913

Extended-spectrum cephalosporin use

3 (5)

16 (29)

0.001b

   Duration, days

1 ± 3

2 ± 5

0.002

Carbapenem use

5 (8)

7 (12)

0.306

   Duration, days

3 ± 3

4 ± 1

0.428

Aminoglycoside use

10 (16)

15 (27)

0.233

   Duration, days

2 ± 5

2 ± 4

0.154

Metronidazole use

4 (7)

3 (6)

0.559

   Duration, days

0.4 ± 2

0.3 ± 2

0.785

  1. Data are presented as mean ± standard deviation or number (percentage). Odds ratio (95% confidence interval) = a3.8 (1.5 to 10) and b7.3 (1.9 to 26.9).